Pharmacy market study in Chambéry 2026

Market context

A pharmacy in Chambéry generates 1.5M €-4.5M € € revenue, with net margin of 8 %. Typical mix: 75-85 % prescription drugs (regulated margin), 15-25 % OTC/wellness (free margin 35-45 %).

Key indicators

Initial investment

800K € → 3.5M €

Depending on location and positioning

Year 1 revenue

1.5M € → 4.5M €

Year 1 target, ramp to 1.2-1.4x by year 3

Average ticket

18 € → 45 €

8 % target net margin

Payback period

96 months

Typical steady-state payback

Economic profile of the area

Population

60K inhabitants

Auvergne-Rhône-Alpes

Country

France

Tier 3 — secondary city

Setup cost

national average

Rent + labor index

Purchasing power

national average

Local disposable income

Dominant profile: touristique

Competition and positioning

Competitive density: moderate (first-mover advantage possible).

Dominant players: regulated public-insurance sector, few private chains.

Positioning recommendation: Competitive positioning required: sector margin is tight, edge comes from operational efficiency.

3-year financial projections

Indicator	Year 1	Year 2	Year 3
Year 1 revenue	1.5M € → 4.5M €	×1,18 (ramp-up)	×1,32 (steady-state)
Target net margin	negative to low	4 %	10 %
Working capital (days of revenue)	45-60 d	35-50 d	30-45 d
Cumulative ROI	investment	~50 %	Payback at 96 months

These ratios are calibrated on MarketLens sector benchmarks and adjusted by local coefficients of Chambéry (cost national average, income national average).

Main risks to anticipate

Strict regulation (health authorities, professional bodies)
Long approval and setup timelines (6-18 months)
Pricing pressure from health insurance schemes
Dependency on a key non-replaceable practitioner
Heavy equipment investment with long depreciation

Frequently asked questions

How to value a pharmacy in Chambéry?

Standard method: revenue multiplier (80-110 %, 90 % average in Chambéry). Adjusting criteria: gross margin, margin/revenue ratio, revenue structure (% wellness), large-prescription weight, public-health dispensary, real estate (lease premium, area, windows), staff in place, local competition.

Financing for a pharmacy acquisition?

Typical mix: personal contribution 25-35 % (rest to finance = 600K-2.5M €), main bank loan over 12-15 years (specialized pharmacy banks), supplementary loan from drug wholesalers, mutual guarantee, sometimes shareholder agreement. Bank targets cash flow >5 % of revenue after debt service.

What net margin to expect?

Average net margin 8 % of revenue. Gross margin 26-32 % (prescription 22-26 %, OTC 30-38 %, wellness 35-45 %). Main expenses: payroll 12-16 %, rent 1.5-3.5 %, other fixed 4-7 %, financial charges 3-8 %. Top lever is product mix (wellness).

How to grow pharmacy revenue?

Levers: wellness range expansion (baby, dermo-cosmetics, nutrition, sport), in-pharmacy services (vaccination, tests, screening, paid pharmaceutical interviews), e-commerce and click & collect, partnerships with care homes and local associations, dedicated counseling space.

Generate your full study and business plan in minutes

MarketLens combines AI market study, business plan calibrated for 24 countries, and post-launch monitoring. Everything exportable to PDF, PowerPoint, Excel and Word.

Start my study → See an example